Goudarzi S, et al. Effect of vitamins and dietary supplements on cardiovascular health. Critical Paths in Cardiology. Natural Medicines. Arenas-Jal M, et al. Coenzyme Q10 supplementation: Efficacy, safety, and formulation challenges.

Comprehensive Reviews in Food Science and Food Safety. Mayo Clinic Press Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press. Mayo Clinic on Incontinence - Mayo Clinic Press Mayo Clinic on Incontinence The Essential Diabetes Book - Mayo Clinic Press The Essential Diabetes Book Mayo Clinic on Hearing and Balance - Mayo Clinic Press Mayo Clinic on Hearing and Balance FREE Mayo Clinic Diet Assessment - Mayo Clinic Press FREE Mayo Clinic Diet Assessment Mayo Clinic Health Letter - FREE book - Mayo Clinic Press Mayo Clinic Health Letter - FREE book.

ART Home Coenzyme Q Show the heart some love! Give Today. Help us advance cardiovascular medicine. Find a doctor. Explore careers. Sign up for free e-newsletters.

About Mayo Clinic. About this Site. Contact Us. Health Information Policy. Media Requests. News Network. Price Transparency. Medical Professionals. Clinical Trials.

Mayo Clinic Alumni Association. Refer a Patient. Executive Health Program. International Business Collaborations. Supplier Information. Nonetheless, more recent studies have suggested that supplemental coenzyme Q 10 could promote mitochondrial biogenesis and respiration 18, 19 and delay senescence in transgenic mice Presently, there is limited scientific evidence to suggest that coenzyme Q 10 supplementation prolongs life or prevents age-related functional declines in humans.

Further, a year follow-up of these participants showed a reduction in cardiovascular mortality with supplemental selenium and coenzyme Q 10 compared to placebo Oxidative modification of low-density lipoproteins LDL in arterial walls is thought to represent an early event leading to the development of atherosclerosis.

Reduced coenzyme Q 10 CoQ 10 H 2 inhibits the oxidation of LDL in the test tube in vitro and works together with α-tocopherol α-TOH to inhibit LDL oxidation by regenerating α-TO· back to α-TOH. In the absence of a co- antioxidant , such as CoQ 10 H 2 or vitamin C, α-TO· can, under certain conditions, promote the oxidation of LDL in vitro 6.

Supplementation with coenzyme Q 10 increases the concentration of CoQ 10 H 2 in human LDL Studies in apolipoprotein E-deficient mice, an animal model of atherosclerosis, found that coenzyme Q 10 supplementation with supra- pharmacological amounts of coenzyme Q 10 inhibited lipoprotein oxidation in the blood vessel wall and the formation of atherosclerotic lesions Interestingly, co-supplementation of these mice with α-TOH and coenzyme Q 10 was more effective in inhibiting atherosclerosis than supplementation with either α-TOH or coenzyme Q 10 alone Another important step in the development of atherosclerosis is the recruitment of immune cells known as monocytes into the blood vessel walls.

This recruitment is dependent in part on monocyte expression of cell adhesion molecules integrins. Although coenzyme Q 10 supplementation shows promise as an inhibitor of LDL oxidation and atherosclerosis, more research is needed to determine whether coenzyme Q 10 supplementation can inhibit the development or progression of atherosclerosis in humans.

Inherited coenzyme Q 10 deficiencies are rare diseases that are clinically and genetically heterogeneous see Deficiency.

Early treatment with pharmacological doses of coenzyme Q 10 is essential to limit irreversible organ damage in coenzyme Q 10 -responsive deficiencies 1. It is not clear to what extent coenzyme Q 10 supplementation might have therapeutic benefit in patients with inherited secondary Q 10 deficiencies.

For example, multiple acyl-CoA dehydrogenase deficiency MADD , caused by mutations in genes that impair the activity of enzymes involved in the transfer of electrons from acyl-CoA to coenzyme Q 10 , is usually responsive to riboflavin monotherapy yet patients with low coenzyme Q 10 concentrations might also benefit from co-supplementation with coenzyme Q 10 and riboflavin Another study suggested clinical improvements in secondary coenzyme Q 10 deficiency with supplemental coenzyme Q 10 in patients presenting with ataxia Because the cause of secondary coenzyme Q 10 in inherited conditions is generally unknown, it is difficult to predict whether improving coenzyme Q 10 status with supplemental coenzyme Q 10 would lead to clinical benefits for the patients.

Finally, coenzyme Q 10 deficiency can be secondary to the inhibition of HMG-CoA reductase by statin drugs see Deficiency. The trials failed to establish a diagnosis of relative coenzyme Q 10 deficiency before the intervention started, hence limiting the conclusion of the meta-analysis.

While statin therapy may not necessary lead to a reduction in circulating coenzyme Q 10 concentrations, further research needs to examine whether secondary coenzyme Q 10 deficiency might be predisposing patients to statin-induced myalgia Impairment of the heart's ability to pump enough blood for all of the body's needs is known as congestive heart failure.

In coronary heart disease CHD , accumulation of atherosclerotic plaque in the coronary arteries may prevent parts of the cardiac muscle from getting adequate blood supply, ultimately resulting in heart damage and impaired pumping ability.

Heart failure can also be caused by myocardial infarction , hypertension , diseases of the heart valves, cardiomyopathy , and congenital heart diseases.

Because physical exercise increases the demand on the weakened heart, measures of exercise tolerance are frequently used to monitor the severity of heart failure.

Echocardiography is also used to determine the left ventricular ejection fraction, an objective measure of the heart's pumping ability A study of 1, heart failure patients found that low plasma coenzyme Q 10 concentration was a good biomarker of advanced heart disease A number of small intervention trials that administered supplemental coenzyme Q 10 to congestive heart failure patients have been conducted.

Pooling data from some of the trials showed an increase in serum coenzyme Q 10 concentrations three studies but no effect on left ventricular ejection fraction two studies or exercise capacity two studies The heart muscle may become oxygen-deprived ischemic as the result of myocardial infarction or during cardiac surgery.

Increased generation of reactive oxygen species ROS when the heart muscle's oxygen supply is restored reperfusion might be an important contributor to myocardial damage occurring during ischemia-reperfusion Pretreatment of animals with coenzyme Q 10 has been found to preserve myocardial function following ischemia-reperfusion injury by increasing ATP concentration, enhancing antioxidant capacity and limiting oxidative damage , regulating autophagy , and reducing cardiomyocyte apoptosis Another potential source of ischemia-reperfusion injury is aortic clamping during some types of cardiac surgery, such as coronary artery bypass graft CABG surgery.

In a small randomized controlled trial in 30 patients, oral administration of coenzyme Q 10 for 7 to 10 days before CABG surgery reduced the need for mediastinal drainage, platelet transfusion, and positive inotropic drugs e. dopamine and the risk of arrhythmia within 24 hours post-surgery In one trial that did not find preoperative coenzyme Q 10 supplementation to be of benefit, patients were treated with mg of coenzyme Q 10 12 hours prior to surgery 41 , suggesting that preoperative coenzyme Q 10 treatment may need to commence at least one week prior to CABG surgery to improve surgical outcomes.

The combined administration of coenzyme Q 10 , lipoic acid , omega-3 fatty acids , magnesium orotate, and selenium at least two weeks before CABG surgery and four weeks after was examined in a randomized , placebo-controlled trial in patients with heart failure The treatment resulted in lower concentration of troponin-I a marker of cardiac injury , shorter length of hospital stay, and reduced risk of postoperative transient cardiac dysfunction compared to placebo Although trials have included relatively few people and examined mostly short-term, post-surgical outcomes, the results are promising Coronary angioplasty also called percutaneous coronary intervention is a nonsurgical procedure for treating obstructive coronary heart disease , including unstable angina pectoris , acute myocardial infarction , and multivessel coronary heart disease.

Angioplasty involves temporarily inserting and inflating a tiny balloon into the clogged artery to help restore the blood flow to the heart. Periprocedural myocardial injury that occurs in up to one-third of patients undergoing otherwise uncomplicated angioplasty increases the risk of morbidity and mortality at follow-up.

A prospective cohort study followed 55 patients with acute ST segment elevation myocardial infarction a type of heart attack characterized by the death of some myocardial tissue who underwent angioplasty Plasma coenzyme Q 10 concentration one month after angioplasty was positively correlated with less inflammation and oxidative stress and predicted favorable left ventricular end-systolic volume remodeling at six months One randomized controlled trial has examined the effect of coenzyme Q 10 supplementation on periprocedural myocardial injury in patients undergoing coronary angioplasty The administration of mg of coenzyme Q 10 12 hours before the angioplasty to 50 patients reduced the concentration of C-reactive protein [CRP]; a marker of inflammation within 24 hours following the procedure compared to placebo.

However, there was no difference in concentrations of two markers of myocardial injury creatine kinase and troponin-I or in the incidence of major adverse cardiac events one month after angioplasty between active treatment and placebo Additional trials are needed to examine whether coenzyme Q 10 therapy can improve clinical outcomes in patients undergoing coronary angioplasty.

Myocardial ischemia may also lead to chest pain known as angina pectoris. People with angina pectoris often experience symptoms when the demand for oxygen exceeds the capacity of the coronary circulation to deliver it to the heart muscle, e.

In most of the studies, coenzyme Q 10 supplementation improved exercise tolerance and reduced or delayed electrocardiographic changes associated with myocardial ischemia compared to placebo. However, only two of the studies found significant decreases in symptom frequency and use of nitroglycerin with coenzyme Q 10 supplementation.

Presently, there is only limited evidence suggesting that coenzyme Q 10 supplementation would be a useful adjunct to conventional angina therapy. Very few high-quality trials have examined the potential therapeutic benefit of coenzyme Q 10 supplementation in the treatment of primary hypertension In contrast, a meta-analysis that used less stringent selection criteria included 17 small trials and found evidence of a blood pressure-lowering effect of coenzyme Q 10 in patients with cardiovascular disease or metabolic disorders The effect of coenzyme Q 10 on blood pressure needs to be examined in large, well-designed clinical trials.

Endothelial dysfunction: Normally functioning vascular endothelium promotes blood vessel relaxation vasodilation when needed for example, during exercise and inhibits the formation of blood clots.

Atherosclerosis is associated with impairment of vascular endothelial function, thereby compromising vasodilation and normal blood flow. Endothelium-dependent vasodilation is impaired in individuals with elevated serum cholesterol concentrations, as well as in patients with coronary heart disease or diabetes mellitus.

Evidence from larger studies is needed to further establish the effect of coenzyme Q 10 on endothelium-dependent vasodilation. Recently published pooled analyses of these trials have given mixed results Larger studies are needed to examine the effect of coenzyme Q 10 supplementation on low-grade inflammation.

Blood lipids : Elevated plasma lipoprotein a concentration is an independent risk factor for cardiovascular disease. Other effects of coenzyme Q 10 on blood lipids have not been reported 51, 53, A therapeutic approach combining coenzyme Q 10 with other antioxidants might prove to be more effective to target co-existing metabolic disorders in individuals at risk for cardiovascular disease Diabetes mellitus is a condition of increased oxidative stress and impaired energy metabolism.

Plasma concentrations of reduced coenzyme Q 10 CoQ 10 H 2 have been found to be lower in diabetic patients than healthy controls after normalization to plasma cholesterol concentrations 56, Randomized controlled trials that examined the effect of coenzyme Q 10 supplementation found little evidence of benefits on glycemic control in patients with diabetes mellitus.

Maternally inherited diabetes mellitus-deafness syndrome MIDD is caused by a mutation in mitochondrial DNA , which is inherited exclusively from one's mother. Of note, the pathogenesis of type 2 diabetes mellitus involves the early onset of glucose intolerance and hyperinsulinemia associated with the progressive loss of tissue responsiveness to insulin.

Recent experimental studies tied insulin resistance to a decrease in coenzyme Q 10 expression and showed that supplementation with coenzyme Q 10 could restore insulin sensitivity 7.

Coenzyme Q 10 supplementation might thus be a more useful tool for the primary prevention of type 2 diabetes rather than for its management. Parkinson's disease is a degenerative neurological disorder characterized by tremors, muscular rigidity, and slow movements.

Mitochondrial dysfunction and oxidative damage in a part of the brain called the substantia nigra may play a role in the development of the disease Decreased ratios of reduced -to- oxidized coenzyme Q 10 have been found in platelets of individuals with Parkinson's disease 61, Two recent meta-analyses of randomized, placebo-controlled trials found no evidence that coenzyme Q 10 improved motor-related symptoms or delayed the progression of the disease when compared to placebo 68, Huntington's disease is an inherited neurodegenerative disorder characterized by selective degeneration of nerve cells known as striatal spiny neurons.

Symptoms, such as movement disorders and impaired cognitive function, typically develop in the fourth decade of life and progressively deteriorate over time. Animal models indicate that impaired mitochondrial function and glutamate -mediated neurotoxicity may be involved in the pathology of Huntington's disease.

Interestingly, co-administration of coenzyme Q 10 with remacemide an NMDA receptor antagonist , the antibiotic minocycline, or creatine led to greater improvements in most biochemical and behavioral parameters To date, only two clinical trials have examined whether coenzyme Q 10 might be efficacious in human patients with Huntington's disease.

All dosages were generally well tolerated, with gastrointestinal symptoms being the most frequently reported adverse effect.

Blood concentrations of coenzyme Q 10 at the end of the study were maximized with the daily dose of 2, mg The trial was prematurely halted because it appeared unlikely to demonstrate any health benefit in supplemented patients — about one-third of participants completed the trial at the time of study termination Although coenzyme Q 10 is generally well tolerated, there is no evidence that supplementation can improve functional and cognitive symptoms in Huntington's disease patients.

Friedreich's ataxia FRDA : FRDA is an autosomal recessive neurodegenerative disease caused by mutations in the gene FXN that encodes for the mitochondrial protein , frataxin.

Frataxin is needed for the making of iron -sulfur clusters ISC. ISC-containing subunits are especially important for the mitochondrial respiratory chain and for the synthesis of heme -containing proteins Frataxin deficiency is associated with imbalances in iron-sulfur containing proteins, mitochondrial respiratory chain dysfunction and lower ATP production, and accumulation of iron in the mitochondria, which increases oxidative stress and oxidative damage to macromolecules of the respiratory chain Clinically, FRDA is a progressive disease characterized by ataxia , areflexia , speech disturbance dysarthria , sensory loss, motor dysfunction, cardiomyopathy , diabetes , and scoliosis Follow-up assessments at 47 months indicated that cardiac and skeletal muscle improvements were maintained and that FRDA patients showed significant increases in fractional shortening, a measure of cardiac function.

Moreover, the therapy was effective at preventing the progressive decline of neurological function Large-scale, randomized controlled trials are necessary to determine whether coenzyme Q 10 , in conjunction with vitamin E, has therapeutic benefit in FRDA. At present, about one-half of patients use coenzyme Q 10 and vitamin E supplements despite the lack of proven therapeutic benefit Spinocerebellar ataxias SCAs : SCAs are a group of rare autosomal dominant neurodegenerative diseases characterized by gait difficulty, loss of hand dexterity, dysarthria, and cognitive decline.

SCA1, 2, 3, and 6 are the most common SCAs In vitro coenzyme Q 10 treatment of forearm skin fibroblasts isolated from patients with SCA2 was found to reduce oxidative stress and normalize complex I and II-III activity of the mitochondrial respiratory chain Early interest in coenzyme Q 10 as a potential therapeutic agent in cancer was stimulated by an observational study that found that individuals with lung, pancreas , and especially breast cancer were more likely to have low plasma coenzyme Q 10 concentrations than healthy controls Two randomized controlled trials have explored the effect of coenzyme Q 10 as an adjunct to conventional therapy for breast cancer.

Supplementation with coenzyme Q 10 failed to improve measures of fatigue and quality of life in patients newly diagnosed with breast cancer 84 and in patients receiving chemotherapy There is little evidence that supplementation with coenzyme Q 10 improves athletic performance in healthy individuals.

Most did not find significant differences between the group taking coenzyme Q 10 and the group taking placebo with respect to measures of aerobic exercise performance, such as maximal oxygen consumption VO 2 max and exercise time to exhaustion Two studies actually found significantly greater improvement in measures of anaerobic 87 and aerobic 86 exercise performance with a placebo than with supplemental coenzyme Q More recent studies have suggested that coenzyme Q 10 could help reduce both muscle damage-associated oxidative stress and low-grade inflammation induced by strenuous exercise Studies on the effect of supplementation on physical performance in women are lacking, but there is little reason to suspect a gender difference in the response to coenzyme Q 10 supplementation.

Coenzyme Q 10 is synthesized in most human tissues. The biosynthesis of coenzyme Q 10 involves three major steps: 1 synthesis of the benzoquinone structure from 4-hydroxybenzoate derived from either tyrosine or phenylalanine, two amino acids; 2 synthesis of the polyisoprenoid side chain from acetyl-coenzyme A CoA via the mevalonate pathway; and 3 the joining condensation of these two structures to form coenzyme Q In the mevalonate pathway, the enzyme 3-hydroxymethylglutaryl HMG -CoA reductase, which converts HMG-CoA into mevalonate, is common to the biosynthetic pathways of both coenzyme Q 10 and cholesterol and is inhibited by statins cholesterol-lowering drugs; see Drug interactions 1.

Of note, pantothenic acid formerly vitamin B 5 is the precursor of coenzyme A, and pyridoxine vitamin B 6 , in the form of pyridoxal-5'-phosphate, is required for the conversion of tyrosine to 4-hydroxyphenylpyruvic acid that constitutes the first step in the biosynthesis of the benzoquinone structure of coenzyme Q The extent to which dietary consumption contributes to tissue coenzyme Q 10 concentrations is not clear.

Rich sources of dietary coenzyme Q 10 include mainly meat, poultry, and fish. Other good sources include soybean, corn, olive, and canola oils; nuts; and seeds. Fruit, vegetables, eggs, and dairy products are moderate sources of coenzyme Q 10 Some dietary sources are listed in Table 1.

Coenzyme Q 10 is available without a prescription as a dietary supplement in the US. Coenzyme Q 10 is fat-soluble and is best absorbed with fat in a meal.

Oral supplementation with coenzyme Q 10 is known to increase blood and lipoprotein concentrations of coenzyme Q 10 in humans 2 , 15 , Nonetheless, under certain physiological circumstances e. During pregnancy, the use of coenzyme Q 10 supplements mg twice daily from 20 weeks' gestation was found to be safe Because reliable data in lactating women are not available, supplementation should be avoided during breast-feeding Concomitant use of warfarin Coumadin and coenzyme Q 10 supplements has been reported to decrease the anticoagulant effect of warfarin in a few cases An individual on warfarin should not begin taking coenzyme Q 10 supplements without consulting the health care provider who is managing his or her anticoagulant therapy.

HMG-CoA reductase is an enzyme that catalyzes a biochemical reaction that is common to both cholesterol and coenzyme Q 10 biosynthetic pathways see Biosynthesis. Statins are HMG-CoA reductase inhibitors that are widely used as cholesterol-lowering medications.

Statins can thus also reduce the endogenous synthesis of coenzyme Q Therapeutic use of statins, including simvastatin Zocor , pravastatin Pravachol , lovastatin Mevacor, Altocor, Altoprev , rosuvastatin Crestor , and atorvastatin Lipitor , has been shown to decrease circulating coenzyme Q 10 concentrations However, because coenzyme Q 10 circulates with lipoproteins , plasma coenzyme Q 10 concentration is influenced by the concentration of circulating lipids , It is likely that circulating coenzyme Q 10 concentrations are decreased because statins reduce circulating lipids rather than because they inhibit coenzyme Q 10 synthesis In addition, very few studies have examined coenzyme Q 10 concentrations in tissues other than blood such that the extent to which statin therapy affects coenzyme Q 10 concentrations in the body's tissues is unknown , , Finally, there is currently little evidence to suggest that secondary coenzyme Q 10 deficiency is responsible for statin-associated muscle symptoms in treated patients.

In addition, supplementation with coenzyme Q 10 failed to relieve myalgia in statin-treated patients see Disease Treatment , Originally written in by: Jane Higdon, Ph. Linus Pauling Institute Oregon State University. Updated in February by: Victoria J.

Drake, Ph. Updated in March by: Victoria J. Updated in April by: Barbara Delage, Ph. Reviewed in May by: Roland Stocker, Ph. Centre for Vascular Research School of Medical Sciences Pathology and Bosch Institute Sydney Medical School The University of Sydney Sydney, New South Wales, Australia.

Acosta MJ, Vazquez Fonseca L, Desbats MA, et al. Coenzyme Q biosynthesis in health and disease. Biochim Biophys Acta. Crane FL. Biochemical functions of coenzyme Q J Am Coll Nutr.

Nohl H, Gille L. The role of coenzyme Q in lysosomes. In: Kagan VEQ, P. Coenzyme Q: Molecular Mechanisms in Health and Disease. Boca Raton: CRC Press; Navas P, Villalba JM, de Cabo R. The importance of plasma membrane coenzyme Q in aging and stress responses.

Ernster L, Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Thomas SR, Stocker R. Mechanisms of antioxidant action of ubiquinol for low-density lipoprotein. In: Kagan VE, Quinn PJ, eds. Fazakerley DJ, Chaudhuri R, Yang P, et al. Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance.

Kagan VE, Fabisak JP, Tyurina YY. Independent and concerted antioxidant functions of coenzyme Q. Overvad K, Diamant B, Holm L, Holmer G, Mortensen SA, Stender S.

Coenzyme Q10 in health and disease. Eur J Clin Nutr. Hargreaves IP. Coenzyme Q10 as a therapy for mitochondrial disease. Int J Biochem Cell Biol. Fragaki K, Chaussenot A, Benoist JF, et al.

Coenzyme Q10 defects may be associated with a deficiency of Qindependent mitochondrial respiratory chain complexes. Biol Res. Kalén A, Appelkvist EL, Dallner G. Age-related changes in the lipid compositions of rat and human tissues. Hernandez-Camacho JD, Bernier M, Lopez-Lluch G, Navas P.

Coenzyme Q10 Supplementation in Aging and Disease. Front Physiol. Beckman KB, Ames BN. Mitochondrial aging: open questions. Ann N Y Acad Sci. Singh RB, Niaz MA, Kumar A, Sindberg CD, Moesgaard S, Littarru GP.

Effect on absorption and oxidative stress of different oral Coenzyme Q10 dosages and intake strategy in healthy men. The effect of coenzyme Q10 supplementation on metabolic status of type 2 diabetic patients.

Minerva Gastroenterol Dietol. Lafuente R, Gonzalez-Comadran M, Sola I, et al. Conezyme Q10 and male infertility: a meta-analysis. J Assist Reprod Genet. Langsjoen PH, Langsjoen JO, Langsjoen AM, Lucas LA.

Treatment of statin adverse effects with supplemental Coenzyme Q10 and statin drug discontinuation. Lee BJ, Tseng YF, Yen CH, Lin PT. Nutr J. Levy G, Kaufmann P, Buchsbaum R, et al. Madmani ME, Yusuf Solaiman A, Tamr Agha K, et al. Coenzyme Q10 for heart failure.

Cochrane Database Syst Rev. McCarty MF. Toward practical prevention of type 2 diabetes. Med Hypotheses. Nahas R. Complementary and alternative medicine approaches to blood pressure reduction: An evidence-based review.

Can Fam Physician. Ochiai A, Itagaki S, Kurokawa T, Kobayashi M, Hirano T, Iseki K. Improvement in intestinal coenzyme q10 absorption by food intake. Yakugaku Zasshi. Ostrowski RP. Effect of coenzyme Q 10 on biochemical and morphological changes in experimental ischemia in the rat brain.

Brain Res Bull. Palan PR, Connell K, Ramirez E, Inegbenijie C, Gavara RY, Ouseph JA, Mikhail MS. Effects of menopause and hormone replacement therapy on serum levels of coenzyme Q10 and other lipid-soluble antioxidants. Quinzii CM, Dimauro S, Hirano M. Human coenzyme q 10 deficiency.

Neurochem Res. Raitakari OT, McCredie RJ, Witting P, Griffiths KA, Letter J, Sullivan D, Stocker R, Celermajer DS. Coenzyme Q improves LDL resistance to ex vivo oxidation but does not enhance endothelial function in hypercholesterolemic young adults. Free Radic Biol Med. Rakel D. Rakel: Integrative Medicine.

Philadelphia, PA: Elsevier Saunders; Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Conenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens. Rosenfeldt F, Hilton D, Pepe S, Krum H.

Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Salles JE, Moises VA, Almeida DR, Chacra AR, Moises RS. Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q Diabetes Res Clin Pract.

Sander S, Coleman CI, Patel AA, Kluger J, White CM. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail. Shults CW, Haas R.

Clinical trials of coenzyme Q10 in neurological disorders. Shults CW. Therapeutic role of coenzyme Q 10 in Parkinson's disease. Pharmacol Ther. Singh U, Devaraj S, Jialal I. Coenzyme Q10 supplementation and heart failure.

Nutr Rev. Spigset O. Reduced effect of warfarin caused by ubidecarenone. Torkos S. Drug-nutrient interactions: A focus on cholesterol-lowering agents. Int J Integrative Med. Watson PS, Scalia GM, Galbraith A, et al. Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure.

J Am Coll Cardiol.

FREE delivery Sun, Feb 18 on your first order. Or fastest delivery Tomorrow, Feb Deal of the Day. Jamieson CoQ10 mg NEW 60 Gummies Gummy.

More results. CoQ10 mg Extra Strength - Coenzyme Q10, Non-GMO, Gluten-Free Softgel. FREE delivery Sun, Feb Small Business. Shop products from Canadian small business brands and discover more about how Amazon empowers small businesses.

Learn more. Webber Naturals Coenzyme Q10 CoQ10 mg, 60 Softgels, High Potency Antioxidant, For Heart Health, Cellular Energy Production, and Migraine Support Softgel.

Nature's Bounty Co Q10 Pills, Promotes Heart Health, mg, 90 Softgels Softgel. Natural Factors PQQ 20 mg · Coenzyme Q10 mg Softgels, 60 Softgels Softgel. AOR - CoEnzyme Q10 mg, 60 Capsules - Ubiquinol CoQ10 mg Capsule for Blood Sugar Control Supplement - Vegan CoQ10 Supplement - Antioxidant and Cardiovascular Supplement Capsule.

Natural Factors - Coenzyme Q mg, Softgels Softgel. Or fastest delivery Fri, Feb Pure Encapsulations - CoQ10 mg - Hypoallergenic Coenzyme Q10 Supplement - 60 Vegetable Capsules Capsule.

COENZYME Q10 Softgel. Policosanol 40mg with 30mg CoQ10 Capsules Capsule. New Roots Herbal - Slow Release CoQ10 Supplement - mg - 60 Capsules - CoQ10 Ubiquinol CoQ10 mg Capsules - Migraine Headache Relief - Migraine Relief Capsules - Cardiovascular Health - Coenzyme Q10 Capsule.

CoQ10 by Nutritionn - Helps Support Cardiovascular Health - mg Capsules - Premium Coenzyme Q10 Ubiquinone Supplement Capsule. Coenzyme Q10 mg 3 X 60 Capsules CoQ10 Heart Health Cardiovascular Blood Pressure Antioxidant Supplement Anti-Aging Ubiquinone Capsule.

See Yourself Well CoQ10 Ubiquinone - Coenzyme Q10 Supplements for Cardiovascular Heart Health and Overall Wellness. High Potency Antioxidant. Small Easy to Swallow Softgels. Take Daily - 60 Softgels. Made in Canada Capsule. Now Foods Ubiquinol mg 60gel Softgel. FREE delivery Feb 23 - Mar 1. Designs for Health CoQnol mg 60 Softgels Softgel.

Designs For Health - Q-Evail softgels gélules. Source Naturals Policosanol with CoQ10, Tablets Tablet. FREE delivery Feb 29 - Mar Or fastest delivery Feb 23 - Jarrow Formulas Co Enzyme Q10, mg, 60 Caps Pack of 2 Capsule.

FREE delivery Mar 7 - Or fastest delivery Feb 21 - Only 5 left in stock. Ages: 15 years and up. Hemani Whole Dried Long Chili - Indian Spice G 3.

Or fastest delivery Feb 16 - See All. DailyOM Courses. About DailyOM Most Popular Courses New Releases Trending Courses See All. By Lauren Bedosky. Medically Reviewed. Justin Laube, MD. Functions Forms Jump to More Topics. What Is Coenzyme Q10? CoQ10 helps cells convert food into energy and is an antioxidant.

Most of us get enough of this substance through diet and natural bodily production, but some have low levels and may benefit from a supplement. CoQ10 may help treat migraines and may improve fertility in men, though more research on these uses is needed.

Who needs to take coenzyme Q10? Most people get enough CoQ10 through a balanced diet and our natural bodily production. Yet supplements may be helpful for people with lower levels of CoQ10, including older adults, people with heart disease or fibromyalgia, and those who take statins.

CoQ10 supplements may also help prevent or treat certain heart conditions and migraine. What are the side effects of taking coenzyme Q10? CoQ10 is generally considered safe, though it may cause mild side effects, such as stomach upset and nausea.

It may also interact with chemotherapy, blood pressure, diabetes, and blood-thinning medications. Can you take coenzyme Q10 every day? The recommended dose for CoQ10 supplementation is 30 to milligrams per day.

What is the best coenzyme Q10 supplement? There are two forms of CoQ10 supplements: ubiquinone naturally occurring CoQ10 and ubiquinol the active form. Ubiquinol is typically better absorbed, which means more of the substance is available for your body to use.

Ubiquinol supplements are also labeled as CoQH or CoQH There are two forms of CoQ10 supplements: ubiquinone and ubiquinol. But for reference, here are some foods that contain CoQ Meat Poultry Fish Nuts Vegetables Soybeans Eggs Dairy products.

May Help Treat Heart Failure CoQ10 may help treat heart failure when used alongside conventional treatment. May Prevent Migraine Attacks According to the American Headache Society , CoQ10 is one of the most commonly used supplements to help prevent migraine.

May Lower Blood Pressure CoQ10 may help lower blood pressure, though the research is mixed. To pick the most effective CoQ10 supplement and maintain its quality, follow these tips. Storage Ubiquinol and CoQ10 supplements can generally withstand higher temperatures in the high 90s Fahrenheit , but they can degrade over time if exposed to heat, per ConsumerLab.

The recommended dose for CoQ10 supplementation is 30 to milligrams per day, per the Icahn School of Medicine at Mount Sinai.

Be sure to work with a healthcare provider to find the right dose for you. Editorial Sources and Fact-Checking. Resources Coenzyme Q Icahn School of Medicine at Mount Sinai. Saini R. Coenzyme Q The Essential Nutrient. July-September Coenzyme Q National Center for Complementary and Integrative Health.

January Antioxidants: In Depth. November Mayo Clinic. November 10, Primary Coenzyme Q10 Deficiency. April 1, What Is the Difference Between CoQ10 and Ubiquinol? August 8, National Cancer Institute.

Dietary Supplements. Food and Drug Administration. March 6, Third-Party Testing Guidance. Sharma A, Fonarow GC, Butler J, et al. Coenzyme Q10 and Heart Failure. Circulation: Heart Failure. March Heart Failure.

Centers for Disease Control and Prevention. January 5, Al Saadi T, Assaf Y, Farwati M, et al. Coenzyme Q10 for Heart Failure. Cochrane Database Systematic Reviews. Zeng Z, Li Y, Lu S, et al. Efficacy of CoQ10 as Supplementation for Migraine: A Meta-Analysis.

Acta Neurologica Scandiavica. Sazali S, Badrin S, Norhayati MN, Idris N. Coenzyme Q10 Supplementation for Prophylaxis in Adult Patients With Migraine: A Meta-Analysis. BMJ Open. Rosenfeldt FL, Haas SJ, Krum H, et al.